(Q46931704)

26 December 2017

title

Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome (English)

1 reference

26 December 2017

1 reference

1 reference

S Hesse

1

1 reference

26 December 2017

C Oehlwein

2

1 reference

26 December 2017

H Barthel

3

1 reference

26 December 2017

J Schwarz

4

1 reference

26 December 2017

D Polster

5

1 reference

26 December 2017

A Wagner

6

1 reference

26 December 2017

O Sabri

7

1 reference

26 December 2017

publication date

6 February 2006

1 reference

26 December 2017

Journal of Neural Transmission

published in

1 reference

26 December 2017

volume

113

1 reference

26 December 2017

issue

9

1 reference

26 December 2017

page(s)

1177-1190

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1007/s00702-005-0401-6

exact match

0 references

cites work

Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0401-6

A comparison of (18)F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0401-6

Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0401-6

Imaging the dopamine system to assess disease-modifying drugs: studies comparing dopamine agonists and levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0401-6

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0401-6

Essential tremor course and disability: A clinicopathologic study of 20 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0401-6

The role of radiotracer imaging in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0401-6

Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0401-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0401-6

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

12 December 2020

Loss of dopamine transporter binding in Parkinson's disease follows a single exponential rather than linear decline.

1 reference

12 December 2020

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

1 reference

12 December 2020

Brain parenchyma sonography detects preclinical parkinsonism.

1 reference

12 December 2020

[123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy.

1 reference

12 December 2020

Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.

1 reference

12 December 2020

Parkinson disease, the effect of levodopa, and the ELLDOPA trial. Earlier vs Later L-DOPA.

1 reference

12 December 2020

Regional serotonin transporter availability and depression are correlated in Wilson's disease

1 reference

12 December 2020

Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging.

1 reference

12 December 2020

SPECT and PET imaging of the dopaminergic system in Parkinson's disease

1 reference

12 December 2020

1 reference

12 December 2020

DAT imaging in drug-induced and psychogenic parkinsonism

1 reference

12 December 2020

Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease

1 reference

12 December 2020

Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes

1 reference

12 December 2020

Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease? For.

1 reference

12 December 2020

Statistical parametric mapping of (99m)Tc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters.

1 reference

12 December 2020

Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT.

1 reference

12 December 2020

Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3‐month observations

1 reference

12 December 2020

Practical importance of neuroprotection in Parkinson's disease

1 reference

12 December 2020

[123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease

1 reference

12 December 2020

Clinical correlates of vascular parkinsonism

1 reference

12 December 2020

Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients

1 reference

12 December 2020

Iodine-123-iodobenzamide binding in parkinsonism: reduction by dopamine agonists but not L-Dopa.

1 reference

12 December 2020

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

1 reference

12 December 2020

Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy

1 reference

12 December 2020

Investigating dopaminergic neurotransmission with 123I-FP-CIT SPECT: comparability of modern SPECT systems

1 reference

12 December 2020

Imaging of dopamine transporters and D2 receptors in vascular parkinsonism: a report of four cases

1 reference

12 December 2020

Downregulation of striatal dopamine D2 receptors in advanced Parkinson's disease contributes to the development of motor fluctuation

1 reference

12 December 2020

[123I]beta-CIT and SPECT in essential tremor and Parkinson's disease.

1 reference

12 December 2020

Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.

1 reference

12 December 2020

Striatal dopamine transporter binding assessed by [I-123]IPT and single photon emission computed tomography in patients with early Parkinson's disease: implications for a preclinical diagnosis

1 reference

12 December 2020

Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy.

1 reference

12 December 2020

Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.

1 reference

12 December 2020

Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial

1 reference

12 December 2020

Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders

1 reference

12 December 2020

Relative quantification of signal on T2-weighted images in the basal ganglia: limited value in differential diagnosis of patients with parkinsonism.

1 reference

12 December 2020

Neurorestoration in Parkinson's disease by cell replacement and endogenous regeneration

1 reference

12 December 2020

Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers

1 reference

12 December 2020

Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes

1 reference

12 December 2020

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group

1 reference

12 December 2020

1 reference

12 December 2020

Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers

1 reference

12 December 2020

Multimodal SPECT and MRT imaging data analysis for an improvement in the diagnosis of idiopathic Parkinson's syndrome

1 reference

12 December 2020

(123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis

1 reference

12 December 2020

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

12 December 2020

Functional brain imaging in the differential diagnosis of Parkinson's disease

1 reference

12 December 2020

Consensus statement on the diagnosis of multiple system atrophy.

1 reference

12 December 2020

Olfactory function in idiopathic Parkinson's disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients

1 reference

12 December 2020

New and reliable MRI diagnosis for progressive supranuclear palsy.

1 reference

12 December 2020

Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.

1 reference

12 December 2020

Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.

1 reference

12 December 2020

[(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy

1 reference

12 December 2020

Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: A decision-analytic approach

1 reference

12 December 2020

Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes.

1 reference

12 December 2020

Accuracy of diagnosis in patients with presumed Parkinson's disease

1 reference

12 December 2020

The L-dopa response in vascular parkinsonism

1 reference

12 December 2020

Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia

1 reference

12 December 2020

The evolution of diagnosis in early Parkinson disease. Parkinson Study Group

1 reference

12 December 2020

10.1007/S00702-005-0401-6

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017